Valuation: IDEXX Laboratories, Inc.

Market Cap 43.6B 219B 38.86B 35.97B 32.56B 61.33B 4,115B 62.06B 431B 169B 2,163B 164B 160B 6,892B P/E 2026 *
37.5x
P/E 2027 * 33.2x
Enterprise Value 43.97B 221B 39.18B 36.28B 32.83B 61.85B 4,149B 62.58B 435B 171B 2,181B 165B 162B 6,950B EV / Sales 2026 *
9.31x
EV / Sales 2027 * 8.46x
Free-Float
72.37%
Yield 2026 *
-
Yield 2027 * -
1 day+2.48%
1 week+5.36%
Current month+4.07%
1 month+6.06%
3 months-2.44%
6 months-3.39%
Current year-25.86%
1 week 560
Extreme 560
560
1 month 509.99
Extreme 509.99
560
Current year 509.99
Extreme 509.99
773.97
1 year 509.99
Extreme 509.99
813.6
3 years 439
Extreme 439
813.6
5 years 336.6
Extreme 336.6
813.6
10 years 225.06
Extreme 225.055
813.6
Manager TitleAgeSince
Chief Executive Officer 52 2026-05-11
Director of Finance/CFO 43 2025-02-28
Chief Operating Officer 58 2024-12-31
Director TitleAgeSince
Chairman 65 2026-05-11
Director/Board Member 64 2013-07-14
Director/Board Member 73 2014-03-10
Change 5-day change 1-year change 3-year change Capi.($)
+2.48%+5.36% - - 43.6B
-1.89%-2.39%-21.19%+3.85% 174B
-2.23%+5.67%-21.63%+12.01% 114B
-1.69%-1.27%-2.92%+27.96% 114B
+0.26%+17.18%-44.04%+5.29% 89.64B
-0.83%+1.27%+3.53%+80.36% 64.96B
-0.47%+5.71%+14.57%+81.93% 56.09B
+0.28%+2.89%+2.81%-24.86% 52.94B
-0.80%+4.63%-13.13%+29.62% 43.6B
+0.18%+1.67%-8.01%-13.57% 32.77B
Average -0.47%+4.44%-10.00%+22.51% 82.44B
Weighted average by Cap. -0.94%+3.58%-13.58%+20.28%

Financials

2026 *2027 *
Net sales 4.72B 23.74B 4.21B 3.9B 3.53B 6.65B 446B 6.72B 46.73B 18.34B 234B 17.72B 17.35B 747B 5.15B 25.85B 4.58B 4.24B 3.84B 7.24B 486B 7.32B 50.89B 19.97B 255B 19.3B 18.9B 813B
Net income 1.18B 5.92B 1.05B 972M 880M 1.66B 111B 1.68B 11.66B 4.58B 58.47B 4.42B 4.33B 186B 1.31B 6.59B 1.17B 1.08B 979M 1.84B 124B 1.87B 12.97B 5.09B 65.05B 4.92B 4.82B 207B
Net Debt 368M 1.85B 328M 303M 274M 517M 34.68B 523M 3.64B 1.43B 18.23B 1.38B 1.35B 58.1B -98.49M -495M -87.77M -81.26M -73.53M -139M -9.29B -140M -974M -382M -4.89B -369M -362M -15.57B
Projected Income Statement - Annual - IDEXX Laboratories, Inc.
Logo IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. is a world leader in the design, development and marketing of diagnostic test instruments for animal health monitoring and analysis of dairy products and water. Net sales break down by area of application as follows: - veterinary diagnoses for pets (91.8%); - water quality analysis (4.7%); - veterinary diagnoses for livestock and poultry (3.1%): solutions that help detect infectious diseases in ruminants, pigs, poultry and horses. The group also offers test solutions for dairy products; - other (0.4%). Net sales by source of income break down between product sales (57.7%) and services (42.3%). Net sales are distributed geographically as follows: the United States (65%), Canada (3.9%), Americas (2.1%), Germany (4.5%), the United Kingdom (3.5%), France (2.9%), Spain (1.6%), Italy (1.5%), Switzerland (0.9%), Netherlands (0.9%), Europe/Middle East/Africa (5.1%), Australia (2.5%), Japan (1.9%), China (0.9%) and Asia/Pacific (2.8%).
Employees
11,000
Date Price Change Volume
26-10-21 R$560.00 +2.48% 5
26-10-15 R$546.43 +2.81% 3
Trader
Investor
Global
Quality
ESG MSCI
-
MarketScreener Ratings - IDEXX Laboratories, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
553.48USD
Average target price
698.00USD
Spread / Average Target
+26.11%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - IDEXX Laboratories, Inc.